Label: NITROGLYCERIN ointment

  • NDC Code(s): 21922-048-05
  • Packager: Encube Ethicals Private Limited
  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated December 17, 2024

If you are a consumer or patient please visit this version.

  • HIGHLIGHTS OF PRESCRIBING INFORMATION
    These highlights do not include all the information needed to use NITROGLYCERIN OINTMENT safely and effectively. See full prescribing information for NITROGLYCERIN OINTMENT. NITROGLYCERIN ointment ...
  • Table of Contents
    Table of Contents
  • 1 INDICATIONS AND USAGE
    Nitroglycerin ointment 0.4% is indicated for the treatment of moderate to severe pain associated with chronic anal fissure.
  • 2 DOSAGE AND ADMINISTRATION
    Apply 1 inch of ointment (375 mg of ointment equivalent to 1.5 mg of nitroglycerin) intra-anally every 12 hours for up to 3 weeks. A finger covering, such as plastic-wrap, disposable surgical ...
  • 3 DOSAGE FORMS AND STRENGTHS
    Ointment, 0.4% w/w (4 mg /1 g) in 30 g tubes.
  • 4 CONTRAINDICATIONS
    4.1 PDE5 inhibitor use - Administration of nitroglycerin ointment is contraindicated in patients who are using a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific ...
  • 5 WARNINGS AND PRECAUTIONS
    5.1 Cardiovascular disorders - Venous and arterial dilatation as a consequence of nitroglycerin treatment including nitroglycerin ointment, can decrease venous blood returning to the heart and ...
  • 6 ADVERSE REACTIONS
    Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials ...
  • 7 DRUG INTERACTIONS
    7.1 PDE5 inhibitors - Phosphodiesterase type 5 (PDE5) inhibitors such as sildenafil, vardenafil, and tadalafil have been shown to potentiate the hypotensive effects of organic nitrates. The time ...
  • 8 USE IN SPECIFIC POPULATIONS
    8.1 Pregnancy - Risk Summary - There are no data on the use of nitroglycerin ointment intra-anally during pregnancy to determine a drug-associated risk of major birth defects, miscarriage or ...
  • 10 OVERDOSAGE
    Nitroglycerin toxicity is generally mild. The estimated adult oral lethal dose of nitroglycerin is 200 mg to 1,200 mg. Infants may be more susceptible to toxicity from nitroglycerin. Consultation ...
  • 11 DESCRIPTION
    Nitroglycerin ointment, USP 0.4% is intended for intra-anal use. Nitroglycerin is 1,2,3,-propanetriol trinitrate, an organic nitrate vasodilator whose structural formula is as follows: and ...
  • 12 CLINICAL PHARMACOLOGY
    12.1 Mechanism of Action - Nitroglycerin forms free radical nitric oxide (NO), which activates guanylate cyclase, resulting in an increase of guanosine 3',5'- monophosphate (cyclic GMP) in smooth ...
  • 13 NONCLINICAL TOXICOLOGY
    13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility - Carcinogenesis - Animal carcinogenicity studies with topically applied nitroglycerin have not been performed. Rats receiving up to 434 ...
  • 14 CLINICAL STUDIES
    Nitroglycerin ointment was evaluated in a 3-week double-blind, randomized, multi-center, placebo- controlled study. Patients with a painful chronic anal fissure for at least 6 weeks and moderate ...
  • 16 HOW SUPPLIED/STORAGE AND HANDLING
    Nitroglycerin ointment, USP 0.4% is available in 30 g (NDC 21922-048-05) aluminum tubes with polyethylene screw caps. Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to ...
  • 17 PATIENT COUNSELING INFORMATION
    Advise the patient to read the FDA-approved patient labeling (Patient Information and Instructions for - Use) Interaction with PDE5 inhibitors - Advise patient not to use nitroglycerin ointment ...
  • PATIENT INFORMATION
    Nitroglycerin (nye" troe glis' er in) Ointment 0.4%   IMPORTANT: For intra-anal use only  - Read the Patient Information that comes with nitroglycerin ointment before you start using ...
  • PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
    NDC 21922-048-05 - Nitroglycerin Ointment, USP 0.4% 30 g - Rx only - Carton Label
  • INGREDIENTS AND APPEARANCE
    Product Information